Insider filings are public records and are not a recommendation.

Results

25+ transactions, newest first

Insider transactions from SEC Form 4 filings, newest first
DateInsiderRelationshipCompanyTransactionSharesPriceValueOwned afterFiling
Kim Hanjoon AlexChief Financial OfficerSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price28,195$0.67$18,890.652,534,859DirectForm 4 filed 24 Aug 2026, on sec.gov (opens in a new tab)Filed 24 Aug 2026
Egholm MichaelDirector, President & CEOSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price97,627$0.67$65,410.096,137,704DirectForm 4 filed 24 Aug 2026, on sec.gov (opens in a new tab)Filed 24 Aug 2026
Mackay SeanSVP & Chief Business OfficerSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price25,729$0.67$17,238.431,480,823DirectForm 4 filed 24 Aug 2026, on sec.gov (opens in a new tab)Filed 24 Aug 2026
Egholm MichaelDirector, President & CEOSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price362,625$0.87$315,483.756,235,331DirectForm 4 filed 4 Aug 2026, on sec.gov (opens in a new tab)Filed 4 Aug 2026
Kim Hanjoon AlexChief Financial OfficerSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price202,476$0.90$182,228.402,563,054DirectForm 4 filed 27 Jul 2026, on sec.gov (opens in a new tab)Filed 27 Jul 2026
Mackay SeanSVP & Chief Business OfficerSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company500,000$0.00$01,506,552DirectForm 4 filed 23 Jun 2026, on sec.gov (opens in a new tab)Filed 23 Jun 2026
Casdin EliDirector, 10% ownerSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company99,116$0.00$03,053,169DirectForm 4 filed 23 Jun 2026, on sec.gov (opens in a new tab)Filed 23 Jun 2026
Cox TroyDirectorSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company99,116$0.00$0475,702DirectForm 4 filed 23 Jun 2026, on sec.gov (opens in a new tab)Filed 23 Jun 2026
Carey Thomas D.DirectorSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company99,116$0.00$0344,456DirectForm 4 filed 23 Jun 2026, on sec.gov (opens in a new tab)Filed 23 Jun 2026
ELOI FENEL MDirectorSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company99,116$0.00$0335,299DirectForm 4 filed 23 Jun 2026, on sec.gov (opens in a new tab)Filed 23 Jun 2026
Witney FrankDirectorSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company99,116$0.00$0309,978DirectForm 4 filed 23 Jun 2026, on sec.gov (opens in a new tab)Filed 23 Jun 2026
HIBBS KATHY LDirectorSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company99,116$0.00$0236,836DirectForm 4 filed 23 Jun 2026, on sec.gov (opens in a new tab)Filed 23 Jun 2026
Egholm MichaelDirector, President & CEOSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price97,626$1.00$97,6266,597,956DirectForm 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026
Mackay SeanSVP & Chief Business OfficerSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price25,729$1.00$25,7291,006,552DirectForm 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026
Kim Hanjoon AlexChief Financial OfficerSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price18,871$1.00$18,8712,760,530DirectForm 4 filed 22 May 2026, on sec.gov (opens in a new tab)Filed 22 May 2026
Egholm MichaelDirector, President & CEOSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price95,014$0.91$86,462.746,695,582DirectForm 4 filed 8 Apr 2026, on sec.gov (opens in a new tab)Filed 8 Apr 2026
Egholm MichaelDirector, President & CEOSTANDARD BIOTOOLS INC.LABOtherM · Option or derivative exercised or converted196,513$0.00$06,790,596DirectForm 4 filed 8 Apr 2026, on sec.gov (opens in a new tab)Filed 8 Apr 2026
Kim Hanjoon AlexChief Financial OfficerSTANDARD BIOTOOLS INC.LABOtherF · Shares withheld to pay tax or exercise price21,301$0.91$19,383.912,779,401DirectForm 4 filed 8 Apr 2026, on sec.gov (opens in a new tab)Filed 8 Apr 2026
Kim Hanjoon AlexChief Financial OfficerSTANDARD BIOTOOLS INC.LABOtherM · Option or derivative exercised or converted70,183$0.00$02,800,702DirectForm 4 filed 8 Apr 2026, on sec.gov (opens in a new tab)Filed 8 Apr 2026
Egholm MichaelDirector, President & CEOSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company1,042,373$0.00$06,594,083DirectForm 4 filed 8 Apr 2026, on sec.gov (opens in a new tab)Filed 8 Apr 2026
Kim Hanjoon AlexChief Financial OfficerSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company323,173$0.00$02,730,519DirectForm 4 filed 8 Apr 2026, on sec.gov (opens in a new tab)Filed 8 Apr 2026
Mackay SeanSVP & Chief Business OfficerSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company272,107$0.00$01,032,281DirectForm 4 filed 8 Apr 2026, on sec.gov (opens in a new tab)Filed 8 Apr 2026
Cox TroyDirectorSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company57,264$1.17$66,998.88376,586DirectForm 4 filed 2 Mar 2026, on sec.gov (opens in a new tab)Filed 2 Mar 2026
Casdin EliDirector, 10% ownerSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company52,991$1.17$61,999.472,954,053DirectForm 4 filed 2 Mar 2026, on sec.gov (opens in a new tab)Filed 2 Mar 2026
Carey Thomas D.DirectorSTANDARD BIOTOOLS INC.LABOtherA · Grant or award from the company51,282$1.17$59,999.94245,340DirectForm 4 filed 2 Mar 2026, on sec.gov (opens in a new tab)Filed 2 Mar 2026

Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.